A new trading day began on Monday, with Immuneering Corp (NASDAQ: IMRX) stock price down -4.69%% from the previous day of trading, before settling in for the closing price of $2.56. IMRX’s price has ranged from $1.00 to $3.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -46.45% over the last five years. Meanwhile, its annual earnings per share averaged 15.20%. With a float of $25.89 million, this company’s outstanding shares have now reached $35.99 million.
The firm has a total of 66 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immuneering Corp (IMRX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immuneering Corp is 28.07%, while institutional ownership is 12.50%. The most recent insider transaction that took place on Jun 18 ’25, was worth 63,188. In this transaction Director of this company bought 25,000 shares at a rate of $2.53, taking the stock ownership to the 136,766 shares. Before that another transaction happened on Jun 18 ’25, when Company’s PRESIDENT AND CEO bought 21,000 for $2.39, making the entire transaction worth $50,144. This insider now owns 2,302,852 shares in total.
Immuneering Corp (IMRX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.75% during the next five years compared to -46.45% drop over the previous five years of trading.
Immuneering Corp (NASDAQ: IMRX) Trading Performance Indicators
Here are Immuneering Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.97, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Immuneering Corp (IMRX)
Analysing the last 5-days average volume posted by the [Immuneering Corp, IMRX], we can find that recorded value of 8.81 million was better than the volume posted last year of 1.39 million. As of the previous 9 days, the stock’s Stochastic %D was 67.41%.
During the past 100 days, Immuneering Corp’s (IMRX) raw stochastic average was set at 67.34%, which indicates a significant increase from 54.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 236.73% in the past 14 days, which was higher than the 114.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.61, while its 200-day Moving Average is $1.86. Now, the first resistance to watch is $2.56. This is followed by the second major resistance level at $2.69. The third major resistance level sits at $2.82. If the price goes on to break the first support level at $2.30, it is likely to go to the next support level at $2.17. Should the price break the second support level, the third support level stands at $2.04.
Immuneering Corp (NASDAQ: IMRX) Key Stats
With a market capitalization of 87.80 million, the company has a total of 35,986K Shares Outstanding. Currently, annual sales are 0 K while annual income is -61,040 K. The company’s previous quarter sales were 0 K while its latest quarter income was -15,050 K.
